Topic: Sts Inhibitory Compounds

I would like to speak with someone who has experience with drug development in the field of immunology, particularly focusing on T cell receptor signaling and infectious diseases. In particular, I would like to discuss the market demand for new inhibitors of Sts1 and Sts2 proteins, as well as the competitive landscape and key players in this space. Ideally, I would like to get a sense of what additional research and development experiments would be necessary to attract interest from companies targeting bacterial and fungal infections, and what critical questions need to be addressed to move forward with new compounds.

Learn More